Preclinical CRO Market, By Service (Drug Metabolism & Pharmacokinetics (DMPK) Studies), and Toxicology Testing), By Application (Respiratory disease, Cardiovascular disease, Infectious disease, Oncology, Diabetes, Immunological disorder, and Others), By End-Users (Medical Device Companies, Pharmaceutical & Biotechnology Companies, Government & Academic Institutes, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Increased rates of urbanization, research and development efforts, and illness prevalence

One of the main drivers of the preclinical CRO market's growth is the rate of urbanization, rising disease prevalence, and R&D activity. The use of processed, frozen, and western foods—all of which are bad for human health—has increased as a result of urbanization. Increased discretionary income due to urbanization has allowed people to improve their lifestyles, consuming more red meat and other animal-derived foods, fats and oils, sugar, sodium, alcohol, and smoke, all of which have a negative impact on health and increase the prevalence of disease. Due to an increase in the number of cars and residential population, urbanization has resulted in changes to the diet, water pollution, and air pollution. Urbanization has had an impact health state brought on by the spread of infectious diseases, health issues linked to pollution, unsuitable housing, and consumption of unnutritious food. Rapid urbanization has led to an increase in crowded settlements, subpar housing, and a lack of sanitary and water infrastructure, all of which have increased the danger of infectious diseases. Infectious infections have increased as a result of poor hygiene at fast food restaurants and rising fast food consumption. For instance, food and water tainted with human feces—which contain pathogens—can spread cholera and typhoid. Arboviral diseases that are well adapted to urban environments, such as Dengue, Chikungunya, and the Zika virus, have emerged and spread as a result of urbanization. Dense and highly connected urban areas have emerged as important hotspots for disease outbreaks, such as COVID-19 and SARS. Medicinal medications have become significant in both the prevention and spread of disease because they boost immunity and help prevent sickness. The market for preclinical CROs has expanded as a result of increased research and development efforts for novel medication development brought on by an increase in disorders. Approximately 55% of the world's population lived in urban areas in 2018, according to UN data, and this number is expected to rise over the course of the forecast period. However, the need for the preclinical CRO market is increased by the rise in disease prevalence, R&D activity, and urban population.